Headline News about Mirum Pharmaceuticals IncVia Benzinga
The Latest Analyst Ratings for Mirum Pharmaceuticals
June 15, 2023
Via Benzinga
Via Talk Markets
Via Benzinga
Mirum Pharmaceuticals: Q1 Earnings Insights
May 04, 2023
Via Benzinga
Analyst Expectations for Mirum Pharmaceuticals's Future
April 06, 2023
Via Benzinga
Via Benzinga
Analyst Expectations for Mirum Pharmaceuticals's Future
March 09, 2023
Via Benzinga
Earnings Preview: Mirum Pharmaceuticals
March 07, 2023
Via Benzinga
Mirum Pharmaceuticals's Return On Capital Employed Insights
December 14, 2022
Via Benzinga
Europe Approves Mirum Pharma's Drug For Rare Genetic Liver Disease
December 13, 2022
Via Benzinga
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 1, 2022
September 01, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|